Julie Yoo has joined Andreessen Horowitz as its latest common companion. She’s going to make investments out of the enterprise capital agency’s bio fund, which closed on $450 million in 2017.
Yoo spent the final eight years as a co-founder and chief product officer of Kyruus, a venture-backed healthcare supplier matching software. She’s joins as a16z’s 17th GP; the agency employed David George, who focuses on late-stage offers, and Anish Acharya, who makes a speciality of fintech offers, as GPs earlier this yr.
Extra notably, Yoo turns into the fourth feminine common companion at a agency that for years had solely males on the high of its ranks. The Slack investor employed its first-ever feminine GP, Katie Haun, in June 2018 to guide its crypto efforts alongside Chris Dixon. Longtime a16z traders Connie Chan and Angela Unusual have been later promoted to GP.
Yoo joins Vijay Pande and Jorge Conde on a16z’s biotech funding workforce. The trio will give attention to life sciences, artificial bio and broader well being tech.
a16z’s latest common companion, Julie Yoo
“As we’ve targeted on these three areas we’ve realized it’s a fairly broad alternative,” Conde tells TechCrunch. “We wished to discover a GP that had the phenotype of what we search for in all of our GPs … and somebody who has deep working experience that is aware of the best way to construct corporations.”
Earlier than co-founding Kyruus, Yoo was the vp of product at Era Well being, a CVS-acquired well being administration firm. In her first function as a enterprise capitalist, Yoo says she’s going to establish investments in corporations remodeling entry to our healthcare system.
“We’re an extension of the phrase ‘software program is consuming the world,’ ” Yoo tells TechCrunch. “We’re targeted on software program consuming care supply and every little thing that flows from that.”
Amongst a16z’s well being and bio investments is Devoted Well being, which helps Medicare beneficiaries entry care by way of its community of physicians and tech-enabled healthcare platform. Different investments within the house embrace Freenome, a liquid biopsy diagnostics platform; Apeel, which makes a type of plant food-based barrier for fruit that goals to interchange wax coatings; a care coordination community known as PatientPing; and BioAge Labs, an organization that’s looking for medication that reach people’ well being span by way of machine studying and biomarkers that velocity up the invention course of.